Catalyst Wire Dossier Catalyst Wire Dossier

intravesical chondroitin sulfate 2%

chondroitin sulfate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intravesical chondroitin sulfate 2%, covering 2020-02-13 to 2020-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis [Phase 4]

See pricing